Changes of enhanced liver fibrosis score predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment

被引：0
|
作者：
Liang, Yan [1 ]
Yip, Terry Cheuk-Fung [1 ]
Lai, Che To [1 ]
Lam, Shuk Man [1 ]
Tse, Yee-Kit [1 ]
Hui, Vicki Wing-Ki [1 ]
Chan, Henry L. Y. [2 ]
Wong, Vincent Wai-Sun [1 ]
Wong, Grace [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[2] Union Hosp, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU414
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [31] Monitoring the effect of antiviral treatment on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients
    Mert, Kamil
    Tatar, Bengu
    Nadir, Yasemin
    Senger, Suheyla Serin
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (12):
  • [32] Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
    Lee, Jaemin
    Yoo, Sun Hong
    Sohn, Won
    Kim, Hyung Woo
    Choi, Yong Sun
    Won, Jung Ho
    Heo, Jin Young
    Park, Sang Jong
    Park, Young Min
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 339 - 349
  • [33] Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment
    Li, Xu
    Jin, Qinglong
    Xu, Hongqin
    Zhang, Zetian
    Zhou, Hongjie
    Yan, Dongqing
    Li, Dongmei
    Gao, Pujun
    Niu, Junqi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3624 - 3630
  • [34] LONG-TERM PREDICTION MODEL FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING ANTIVIRAL THERAPY
    Lee, Ji Hun
    Shin, Seung Kak
    Kang, Seong Hee
    Kim, Taehyung
    Yim, Hyung-Joon
    Young, Yim Sun
    Lee, Young-Sun
    Jung, Young Kul
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yeon, Jong Eun
    Kwon, Oh Sang
    Um, Soon Ho
    Byun, Kwan Soo
    HEPATOLOGY, 2022, 76 : S1344 - S1345
  • [35] PERFORMANCE OF HEPATOCELLULAR CARCINOMA RISK SCORES IN CHRONIC HEPATITIS B PATIENTS RECEIVING ENTECAVIR TREATMENT
    Wong, V. W. -S.
    Wong, G. L. -H.
    Chan, H. -Y.
    Tse, C. -H.
    Chan, H. L. -Y.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S19 - S19
  • [36] Performance of fibrosis biomarkers for stratifying hepatocellular carcinoma risk in patients under antiviral therapy for chronic hepatitis B
    Lee, Sang-geul
    Song, Byeong Geun
    Sinn, Dong Hyun
    Kang, Won-seok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY, 2017, 66 : 1014A - 1014A
  • [37] Hepatitis B vaccination in patients receiving antiviral monotherapy after liver transplantation for chronic hepatitis B
    Wong, Tiffany
    Fung, James Y. Y.
    Chan, See Ching
    Lo, Chung Mau
    TRANSPLANTATION, 2016, 100 (07) : S276 - S277
  • [38] Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy
    Seo, Yeon Seok
    Kim, Mi Na
    Kim, Seung Up
    Kim, Sang Gyune
    Um, Soon Ho
    Han, Kwang-Hyub
    Kim, Young Seok
    MEDICINE, 2016, 95 (12)
  • [39] Hepatocellular carcinoma risks of liver fibrosis changes after viral eradication in chronic hepatitis C patients
    Liu, Yen-Chun
    Hsu, Cheng Er
    Cheng, Ya-Ting
    Su, Chung-Wei
    Tai, Chia-Hung
    Chen, Yi-Cheng
    Teng, Wei
    Jeng, Rachel Wen-Juei
    Lin, Chun-yen
    Chien, Rong-Nan
    Dar-In, Tai
    Sheen, I-Shyan
    JOURNAL OF HEPATOLOGY, 2022, 77 : S576 - S577
  • [40] Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
    Wong, Grace Lai-Hung
    Chan, Henry Lik-Yuen
    Wong, Catherine Ka-Yan
    Leung, Calvin
    Chan, Candace Yim
    Ho, Patricia Po-Lai
    Chung, Vivian Chi-Yee
    Chan, Zhan Cham-Yan
    Tse, Yee-Kit
    Chim, Angel Mei-Ling
    Lau, Tina Kit-Ting
    Wong, Vincent Wai-Sun
    JOURNAL OF HEPATOLOGY, 2014, 60 (02) : 339 - 345
12345